Literature DB >> 15339860

Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines.

Cécile Mahé1, Michel Bernhard, Ionel Bobirnac, Corinna Keser, Erika Loetscher, Dominik Feuerbach, Kumlesh K Dev, Philippe Schoeffter.   

Abstract

Serotonin 5-HT(7) receptors are present in astrocytes. Understanding their role in this type of cell would greatly benefit from the identification of astroglial cell lines expressing this receptor type. The aim of the present study was to assess the expression of native 5-HT(7) receptors and 5-HT(7) receptor mRNA in a number of human glioblastoma cell lines, by means of cAMP measurements, Western blot analysis and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. 5-Hydroxytryptamine (5-HT), 5-carboxamidotryptamine (5-CT), 5-methoxytryptamine (5-MeOT) and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) induced concentration-dependent stimulations of cAMP accumulation in the human glioblastoma cell lines, U-373 MG, U-138 MG, U-87 MG, DBTRG-05MG, T98G, H4, CCF-STTG1 and Hs 683. The rank order of potency was 5-CT>5-HT=5-MeOT>>8-OH-DPAT. The effect of 5-CT was inhibited in a concentration-dependent manner by the selective 5-HT(7) receptor antagonist SB-269970 in all human glioblastoma cells. Schild analyses yielded slope factors close to unity (0.89-1.13) and pA(2) values of 8.69-9.05. Western blot analysis revealed the presence of immunoreactive bands corresponding to the human 5-HT(7) receptor in extracts of all human glioblastoma cell lines. The presence of the three splice variants of the 5-HT(7) receptor (5-HT(7(a/b/d))) was visualized by RT-PCR analysis with specific primers in all human glioblastoma cell lines. In conclusion, human glioblastoma cell lines express functional 5-HT(7) receptors and the three splice variants of the corresponding mRNA. These cell lines could serve as model systems of native 5-HT(7) receptors in glial cells to investigate their putative role in processes like release of neurotrophic factors or inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339860      PMCID: PMC1575348          DOI: 10.1038/sj.bjp.0705936

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).

Authors:  P J Lovell; S M Bromidge; S Dabbs; D M Duckworth; I T Forbes; A J Jennings; F D King; D N Middlemiss; S K Rahman; D V Saunders; L L Collin; J J Hagan; G J Riley; D R Thomas
Journal:  J Med Chem       Date:  2000-02-10       Impact factor: 7.446

Review 2.  New roles for astrocytes (stars at last).

Authors:  Bruce Ransom; Toby Behar; Maiken Nedergaard
Journal:  Trends Neurosci       Date:  2003-10       Impact factor: 13.837

Review 3.  5-HT7 receptors.

Authors:  David R Thomas; Jim J Hagan
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2004-02

4.  5-HT7 receptors modulate synchronized network activity in rat hippocampus.

Authors:  Catherine H Gill; Ellen M Soffin; Jim J Hagan; Ceri H Davies
Journal:  Neuropharmacology       Date:  2002-01       Impact factor: 5.250

5.  Subcellular distribution of 5-HT(1B) and 5-HT(7) receptors in the mouse suprachiasmatic nucleus.

Authors:  M A Belenky; G E Pickard
Journal:  J Comp Neurol       Date:  2001-04-09       Impact factor: 3.215

6.  The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.

Authors:  K A Krobert; T Bach; T Syversveen; A M Kvingedal; F O Levy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-06       Impact factor: 3.000

7.  5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells.

Authors:  W L Bacon; S G Beck
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

8.  A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization.

Authors:  E M Chapin; R Andrade
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

9.  Serotonin suppresses the slow afterhyperpolarization in rat intralaminar and midline thalamic neurones by activating 5-HT(7) receptors.

Authors:  Jean-Marc Goaillard; Pierre Vincent
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

10.  Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase.

Authors:  A P Tsou; A Kosaka; C Bach; P Zuppan; C Yee; L Tom; R Alvarez; S Ramsey; D W Bonhaus; E Stefanich
Journal:  J Neurochem       Date:  1994-08       Impact factor: 5.372

View more
  18 in total

Review 1.  Neuronal Activity in Ontogeny and Oncology.

Authors:  Humsa Venkatesh; Michelle Monje
Journal:  Trends Cancer       Date:  2017-02-13

2.  Glutamate promotes cell growth by EGFR signaling on U-87MG human glioblastoma cell line.

Authors:  Daniel Pretto Schunemann; Ivana Grivicich; Andréa Regner; Lisiane Freitas Leal; Daniela Romani de Araújo; Geraldo Pereira Jotz; Carlos Alexandre Fedrigo; Daniel Simon; Adriana Brondani da Rocha
Journal:  Pathol Oncol Res       Date:  2009-12-08       Impact factor: 3.201

Review 3.  Neuronal activity in the glioma microenvironment.

Authors:  Tessa Johung; Michelle Monje
Journal:  Curr Opin Neurobiol       Date:  2017-11-06       Impact factor: 6.627

Review 4.  An active role for neurons in glioma progression: making sense of Scherer's structures.

Authors:  Shawn Gillespie; Michelle Monje
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 12.300

Review 5.  Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.

Authors:  R E Kast
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 6.  Long-term survival in a patient with glioblastoma on antipsychotic therapy for schizophrenia: a case report and literature review.

Authors:  Shahdabul Faraz; Susan Pannullo; Marc Rosenblum; Andrew Smith; A Gabriella Wernicke
Journal:  Ther Adv Med Oncol       Date:  2016-08-18       Impact factor: 8.168

7.  Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor.

Authors:  Matilde León-Ponte; Gerard P Ahern; Peta J O'Connell
Journal:  Blood       Date:  2006-12-07       Impact factor: 22.113

Review 8.  Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management.

Authors:  Folabomi A Oladosu; William Maixner; Andrea G Nackley
Journal:  Mayo Clin Proc       Date:  2015-08       Impact factor: 7.616

9.  Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways.

Authors:  Vaibhav P Pai; Nelson D Horseman
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

10.  Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions.

Authors:  Malinda A Stull; Vaibhav Pai; Archie J Vomachka; Aaron M Marshall; George A Jacob; Nelson D Horseman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.